Connor Clark & Lunn Investment Management Ltd. Has $921,000 Stake in HealthStream, Inc. $HSTM

Connor Clark & Lunn Investment Management Ltd. lowered its stake in shares of HealthStream, Inc. (NASDAQ:HSTM) by 14.6% during the second quarter, HoldingsChannel reports. The institutional investor owned 33,289 shares of the technology company’s stock after selling 5,709 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in HealthStream were worth $921,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. PNC Financial Services Group Inc. lifted its position in shares of HealthStream by 62.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,625 shares of the technology company’s stock valued at $84,000 after acquiring an additional 1,010 shares during the period. Virtus Advisers LLC acquired a new position in HealthStream in the first quarter valued at about $161,000. Public Employees Retirement System of Ohio lifted its position in HealthStream by 342.2% during the second quarter. Public Employees Retirement System of Ohio now owns 6,407 shares of the technology company’s stock worth $177,000 after purchasing an additional 4,958 shares during the period. Bessemer Group Inc. grew its stake in HealthStream by 21.7% during the second quarter. Bessemer Group Inc. now owns 8,392 shares of the technology company’s stock worth $233,000 after buying an additional 1,495 shares in the last quarter. Finally, Avantax Advisory Services Inc. bought a new position in HealthStream in the 1st quarter valued at about $256,000. Institutional investors own 69.58% of the company’s stock.

HealthStream Stock Performance

NASDAQ HSTM opened at $24.30 on Wednesday. The firm’s fifty day moving average price is $26.75 and its two-hundred day moving average price is $27.18. The stock has a market cap of $720.93 million, a PE ratio of 36.27, a PEG ratio of 3.08 and a beta of 0.43. HealthStream, Inc. has a fifty-two week low of $24.07 and a fifty-two week high of $34.24.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings results on Monday, November 3rd. The technology company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.03. The company had revenue of $76.47 million during the quarter, compared to analysts’ expectations of $75.52 million. HealthStream had a return on equity of 5.70% and a net margin of 6.89%. HealthStream has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that HealthStream, Inc. will post 0.63 earnings per share for the current fiscal year.

HealthStream announced that its board has authorized a share buyback program on Tuesday, November 11th that allows the company to buyback $10.00 million in outstanding shares. This buyback authorization allows the technology company to purchase up to 1.3% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

HealthStream Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Stockholders of record on Monday, November 17th will be issued a dividend of $0.031 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, November 17th. HealthStream’s payout ratio is 17.65%.

Insider Buying and Selling at HealthStream

In other news, EVP Kevin P. O’hara sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $27.97, for a total value of $55,940.00. Following the completion of the transaction, the executive vice president owned 17,137 shares of the company’s stock, valued at $479,321.89. This represents a 10.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 20.50% of the company’s stock.

Analyst Upgrades and Downgrades

HSTM has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of HealthStream from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Weiss Ratings restated a “hold (c)” rating on shares of HealthStream in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group reduced their target price on HealthStream from $29.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, August 7th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, HealthStream presently has a consensus rating of “Hold” and a consensus price target of $28.00.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.